Skip to main content
. 2017 Dec 23;9(3):4134–4149. doi: 10.18632/oncotarget.23642

Figure 2. CD34 expression.

Figure 2

De novo patient samples and HL-60 samples, untreated and treated for 72 h (RA, FRA, BRA), were analyzed for CD34 expression using CD34 APC antibody. Mean expression of the singlet population for each sample is compared using the ggplot2 package in R. For each sample, the wider the boxplot, the greater difference in CD34 expression among C, RA, FRA, BRA. AML 100, AML 61, AML 94 and HL-60 cell line are wt-NPM1.